ConnecticutPerioperative CarePostoperative Complications
Dr. Michal Gillian Rose, MD
NPI1962490904
- Part D claims, 2017
- 11
- Publications
- 28
- Clinical trials
- 4
- Hospital affiliations
- 1
- Industry payments
- $24
- Practice address
- 28 Crescent St, Middletown, CT 06457
- Practice phone
- Call (860) 344-6000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Rose's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michal Gillian Rose is a hematologist and oncologist in Middletown, Connecticut
Dr. Rose practices at Middlesex Hospital in Middletown, Connecticut, part of Middlesex Health System.
Dr. Rose's NPI, 1962490904, was assigned on October 13, 2005. Dr. Rose graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1987. Dr. Rose holds Connecticut license 033348.
NPI and contact details
- NPI
- 1962490904NPI Registry (opens in a new tab)
- NPI enumeration date
- October 13, 2005
- NPI status
- Active
- Practice phone
- (860) 344-6000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Medical school graduation
- 1987
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Michal Gillian Rose practices at Middlesex Hospital in Middletown, Connecticut
Dr. Rose's primary practice is Middlesex Hospital, at 28 Crescent St, Middletown, CT 06457 in Middlesex County. The practice phone is (860) 344-6000.
- Middlesex Hospital28 Crescent St, Middletown, CT 06457 · Middlesex CountyPhone(860) 344-6000
Source: Dmand AI Affiliation Data
Dr. Michal Gillian Rose is affiliated with 1 site of care
Dr. Rose's primary practice is Middlesex Hospital in Middletown, Connecticut, part of Middlesex Health System.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michal Gillian Rose's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rose practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Middlesex Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Rose practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Middlesex Health System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michal Gillian Rose is one of 175 hematologists and oncologists in Connecticut
Hematology and oncology is Dr. Rose's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rose is licensed in Connecticut.
Specialties and state licenses
- Hematology and oncology, ConnecticutPrimary
Hematologists and oncologists near Dr. Rose
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
175hematologists and oncologists in Connecticut
7hematologists and oncologists in Middletown
2hematologists and oncologists at Middlesex HospitalSources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michal Gillian Rose's patients have a median age of 70
Across all payers, Dmand AI patient panel data puts Dr. Rose's median patient age at 70, with 0% women.
Dr. Rose's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women0%
- Men100%
Source: Dmand AI Patient Panel Data
Dr. Michal Gillian Rose wrote 11 Medicare Part D claims in 2017
In 2017, Dr. Rose wrote 11 Medicare Part D claims. They cover 1 drug, with $4,325 in total drug cost.
Part D claims, 201711
Drugs named by CMS1
Total drug cost$4,325
Dr. Rose's most prescribed drugs by claims, 2017
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Rose by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michal Gillian Rose has 28 publications on record
Dmand AI links 28 papers to Dr. Rose, published from 2012 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Connecticut and Lung Neoplasms. Dr. Rose has published most often in Blood. Dr. Rose's most frequent co-authors are Jessica Kaplan Altman, MD, Ellin Berman, MD and Leland L. Metheny, MD.
Papers28
Years published2012 to 2024
Dr. Rose's papers by year, 2012 to 2024
Topics Dr. Rose writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Connecticut
- Lung Neoplasms
- Biopsy
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Electronic Health Records
- Fusion Proteins, bcr-abl
Dr. Rose's most frequent co-authors
- Jessica Kaplan Altman, MD4 shared papers
- Ellin Berman, MD4 shared papers
- Leland L. Metheny, MD4 shared papers
Recent publications by Dr. Rose
JCO Oncol Pract
Carcinoma, HepatocellularLiver Neoplasms
See who Dr. Rose researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rose works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michal Gillian Rose has worked on 4 clinical trials
Dmand AI links Dr. Rose to 4 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Small Cell, Cytopenia and Rectal Diseases. SWOG Cancer Research Network sponsors the most, 2.
Clinical trials with Dr. Rose by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Rose's trials
- Carcinoma, Small Cell
- Cytopenia
- Rectal Diseases
- Carcinoma, Ovarian Epithelial
- Colorectal Neoplasms
Investigators on the most trials with Dr. Rose
- Mehmet Akce, MD2 shared trials
- Sukeshi Patel Arora, MD2 shared trials
- Luke Philip Dreisbach, MD2 shared trials
Recent clinical trials with Dr. Rose
Carcinoma, Small CellCarcinoma, Ovarian EpithelialRRx-001CarboplatinCisplatin
The National Myelodysplastic Syndromes (MDS) Study (opens in a new tab)
Active, not recruiting
CytopeniaMyeloproliferative Disorders
Gemcitabine HydrochloridePaclitaxel Albumin-Stabilized Nanoparticle FormulationFluorouracil
S0820, Adenoma and Second Primary Prevention Trial (opens in a new tab)
Active, not recruitingPhase 3
Rectal DiseasesColorectal NeoplasmsEflornithine plus sulindac
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michal Gillian Rose received $24 in industry payments from 2018 to 2019
CMS Open Payments shows 2 general payments to Dr. Rose from 2 drug and device companies from 2018 to 2019. Education make up the largest share, 100% of the total. Seagen Inc. paid the most, $12.
General payments to Dr. Rose by program year, 2018 to 2019
Companies that paid Dr. Rose the most, 2018 to 2019
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michal Gillian Rose graduated from The Hebrew University of Jerusalem Hadassah Medical School
Dr. Rose graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1987.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Michal Gillian Rose's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michal Gillian Rose
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michal Gillian Rose's NPI number?
Dr. Michal Gillian Rose's NPI number is 1962490904. It was assigned on October 13, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Michal Gillian Rose?
Dr. Michal Gillian Rose is a hematologist and oncologist in Middletown, Connecticut. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Michal Gillian Rose practice?
Dr. Rose practices at 28 Crescent St, Middletown, CT 06457. Dr. Rose's primary practice is Middlesex Hospital in Middletown, Connecticut, part of Middlesex Health System.
What is Dr. Michal Gillian Rose's office phone number?
The practice phone on file for Dr. Rose is (860) 344-6000.
What is Dr. Michal Gillian Rose's medical license number?
Dr. Rose holds Connecticut license 033348.
Which hospitals is Dr. Michal Gillian Rose affiliated with?
Dr. Rose practices at Middlesex Hospital in Middletown, Connecticut.
Where did Dr. Michal Gillian Rose go to medical school?
Dr. Rose graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1987.
What drugs does Dr. Michal Gillian Rose prescribe most?
In 2017 Medicare Part D data, Dr. Rose's most prescribed drugs by claims were Xarelto.
Has Dr. Michal Gillian Rose received payments from drug or device companies?
CMS Open Payments shows $24 in general payments to Dr. Rose from 2 companies from 2018 to 2019. The largest total came from Seagen Inc.
How long has Dr. Michal Gillian Rose been practicing?
Dr. Rose graduated from medical school in 1987, 39 years ago.
Does Dr. Michal Gillian Rose do research?
Dmand AI links 28 publications to Dr. Rose, published from 2012 to 2024. Dr. Rose has worked on 4 clinical trials.
Who does Dr. Michal Gillian Rose publish with?
Dr. Rose's most frequent co-authors are Jessica Kaplan Altman, MD (4 shared papers), Ellin Berman, MD (4 shared papers) and Leland L. Metheny, MD (4 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Connecticut by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card